Delhi Network Of Positive People Opposition, Lenacapavir, (201917006277)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
The Delhi Network of Positive People opposition, Glecaprevir / Pibrentasvir, (201817002543)
Countries: India Date: 2021
-
Delhi Network of Positive People opposition, GSK3036656, (201717032083)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) opposition, Lumacaftor, (3158/KOLNP/2012)
Countries: India Date: 2021
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) opposition, efavirenz (EFV) , (IN/PCT/2000/00553/MUM (granted as: 195367))
Countries: India Date: 2007
-
Delhi Network of Positive People (DNP+) opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))
Countries: India Date: 2009
-
Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate tenofovir disoproxil fumarate (TDF) , (1135/DEL/2007 (divisional to 896/DEL/2002))
Countries: India Date: 2012
-
Delhi Network of Positive People (DNP+) opposition, raltegravir (RAL) , (4187/DELNP/2007)
Countries: India Date: 2013
-
Delhi Network of Positive People (DNP+) opposition, Dolutegravir, (3865/KOLNP/2007)
Countries: India Date: 2013